10:01 AM EST - BELLUS Health Inc. : Announced that Roberto Bellini, President and Chief Executive Officer of BELLUS Health, will present a corporate overview of the Company, including an update on its lead program BLU-5937 for the treatment of chronic cough, at three upcoming healthcare investor conferences. BELLUS Health Inc.
shares T.BLU are trading down $0.01 at $1.35.
